One of these is marketed as the brain product and the other as the stress herb. Line up the human trials on cognition in healthy adults and the labels swap places. A 2026 meta-analysis of 20 randomised trials covering 1,249 participants found ashwagandha significantly improved memory, attention and processing speed, and executive function. Lion's mane's cognition evidence is two small trials in people with existing impairment, plus one 41-person pilot. That isn't the ranking anyone expects.
Ashwagandha's cognitive meta-analysis (20 studies, 1,249 participants) reports memory at SMD 0.52 (95% CI 0.27–0.78), attention and processing speed at SMD 0.29 (0.07–0.51) and executive function at SMD −0.42 (−0.70 to −0.13), plus testosterone at SMD 0.33 and muscle strength at SMD 0.58. Its stress evidence is older and cleaner still: 64 chronically stressed adults on 300 mg twice daily for 60 days showed significant reductions on every stress scale (p < 0.0001) and a substantial serum cortisol drop (p = 0.0006). Lion's mane has Mori's 16-week trial in 30 adults with mild cognitive impairment, Li's 49-week Alzheimer's trial, and Docherty's 2023 pilot in 41 healthy adults aged 18–45 — where a single 1.8 g dose sped up Stroop performance (p = 0.005) and 28 days produced only a trend toward less subjective stress (p = 0.051).
Both are worth buying. They just aren't worth buying for the reasons the packaging gives.
What Does Lion's Mane Actually Have?
Three human trials that matter, and only one of them recruited healthy people.
Mori's 2009 study gave 30 Japanese adults aged 50 to 80 with diagnosed mild cognitive impairment 3 grams a day of dried powder for 16 weeks. Cognitive scores rose significantly against placebo at weeks 8, 12 and 16 — then fell significantly four weeks after the intake stopped. Fifteen people per arm.
Li's 2020 trial ran 49 weeks of erinacine A-enriched mycelium in mild Alzheimer's, where the statistically significant cognitive decline landed in the placebo arm. Our NGF article examines how far the mechanism story behind those results actually reaches.
Docherty's 2023 pilot is the one that speaks to healthy adults, and it's modest. Forty-one people aged 18 to 45 took 1.8 g of Hericium erinaceus; a single dose produced quicker Stroop performance at 60 minutes (p = 0.005), and after 28 days subjective stress showed a trend rather than a result (p = 0.051). The authors report null and limited negative findings alongside those, and say plainly the sample was small.
What Does Ashwagandha Actually Have?
Considerably more, on both endpoints people buy these products for.
On stress, Chandrasekhar's 2012 trial enrolled 64 adults with a history of chronic stress and gave them 300 mg of a high-concentration full-spectrum root extract twice daily for 60 days. Every stress-assessment scale improved significantly against placebo (p < 0.0001), and serum cortisol fell substantially (p = 0.0006). Adverse effects were mild and comparable between groups.
On cognition, Zhu's 2026 meta-analysis pooled 20 randomised trials and 1,249 participants. Memory improved at SMD 0.52 with low heterogeneity, attention and processing speed at SMD 0.29 with none at all, executive function at SMD −0.42, and visuospatial ability at SMD 0.39 once one heterogeneous study was excluded. Most included trials were rated high or moderate quality.
Those effect sizes are small to moderate, which is what honest supplement research looks like. The difference is that there are twenty of them.
Do They Even Target the Same Thing?
Partly, and the overlap is smaller than the marketing suggests.
Ashwagandha's mechanism story runs through the hypothalamic-pituitary-adrenal axis — cortisol, stress response, perceived load. Its cognitive gains are plausibly downstream of that: someone sleeping better and less stressed will test better on attention and memory without any direct neurological effect at all.
Lion's mane's story is structural rather than hormonal: hericenones and erinacines, nerve growth factor signalling, and in Li's trial a preservation of daily function over most of a year. If that mechanism is real, it's doing something ashwagandha isn't.
Which means the fair reading isn't "ashwagandha wins". It's that ashwagandha has better evidence for feeling and performing better now, and lion's mane has the only evidence for holding ground over a year in a population already losing it.
How Do They Compare on the Numbers?
| Lion's mane | Ashwagandha | |
|---|---|---|
| Trials in healthy adults | One pilot, n=41 | Many; 20 pooled in the 2026 meta-analysis |
| Memory | Significant in mild cognitive impairment only | SMD 0.52 (0.27–0.78) pooled |
| Processing speed | Acute Stroop speed, single pilot | SMD 0.29 (0.07–0.51) pooled |
| Stress and cortisol | Trend only (p = 0.051) | All scales p < 0.0001; cortisol p = 0.0006 |
| Longest trial | 49 weeks | Typically 8–12 weeks |
| Effect after stopping | Reversed within four weeks in Mori | Not systematically studied |
| Documented safety concerns | No comparable signal in the 2025 review | Hepatotoxicity case reports; avoid in pregnancy |
| Typical studied dose | 1.8–3 g daily dried, or 1,050 mg mycelium | 300 mg twice daily of root extract |
Which One Is Safer?
Lion's mane, and it's not close either.
Ashwagandha has accumulated a genuine hepatotoxicity file — published cases of liver injury, some with jaundice, generally resolving on withdrawal. It's also contraindicated in pregnancy and interacts with thyroid medication and sedatives. Our ashwagandha liver safety article sets out what's actually documented.
Lion's mane's 2025 systematic review of side effects found nothing of that order; the reported problems are gastrointestinal and occasional skin reactions. See lion's mane side effects for the detail.
So the better-evidenced option is also the one carrying the real safety file. That's an unusual trade and it deserves to be made deliberately rather than by accident.
Can You Take Both?
Yes, and it's one of the more defensible stacks, because they act through different systems and neither is dosed anywhere near a ceiling.
Start one at a time, though. Running both from day one means that if something works — or if your liver enzymes move — you won't know which one did it. Four weeks apart is enough to attribute an effect. Our stacking guide covers sequencing.
Which Should You Buy?
- Shopping for focus as a healthy adult? Ashwagandha has more behind it. Twenty pooled trials beats one 41-person pilot, however uncomfortable that is for the mushroom aisle.
- Concerned about age-related decline? Lion's mane is the only one tested there. Both of its substantial trials recruited people with existing impairment.
- Match the studied dose. Ashwagandha: 300 mg root extract twice daily. Lion's mane: 3 g of dried fruiting body, per our dosage guide.
- Skip ashwagandha if you're pregnant, have liver concerns, or take thyroid medication. That's a hard filter, not a caution.
- Expect maintenance rather than accumulation. Mori's lion's mane gains reversed four weeks after stopping, and nobody has tested what happens when ashwagandha stops.
- If stress is the real problem, treat it as the real problem. Ashwagandha's cortisol result is the strongest single finding either product has — see our stress ranking for where mushrooms sit against it.
The Honest Summary
Ashwagandha out-evidences lion's mane on cognition in healthy adults, which is the exact claim lion's mane is sold on. It also out-evidences it on stress, which is the claim ashwagandha is sold on. On volume and quality of human data this isn't a close comparison.
Two things keep lion's mane in the conversation. It's the only one of the pair with a 49-week trial in a population losing cognitive ground, and it's the one without a hepatotoxicity file. If you want measurable change over eight weeks, the herb has the numbers. If you want the species with long-duration data and a clean safety record, the mushroom has that instead. Buying both is reasonable; buying either for the reason printed on the label is not.
Frequently Asked Questions
Which is better for focus, lion's mane or ashwagandha?
On pooled human evidence, ashwagandha. A 2026 meta-analysis of 20 trials in 1,249 participants found significant improvements in memory (SMD 0.52) and in attention and processing speed (SMD 0.29). Lion's mane's only healthy-adult trial had 41 people in it.
Does lion's mane work in healthy people?
The evidence is thin. A 41-person pilot found quicker Stroop performance 60 minutes after a single 1.8 g dose, but the 28-day stress outcome only reached p = 0.051, and the authors reported null and limited negative findings alongside it.
Is ashwagandha safe to take long-term?
It has a documented hepatotoxicity signal that lion's mane does not, with published liver injury cases generally resolving after stopping. It's also contraindicated in pregnancy and interacts with thyroid medication and sedatives.
Can I take lion's mane and ashwagandha together?
There's no documented interaction, and they act through different systems — one on nerve growth factor signalling, the other on the stress axis. Start them four weeks apart so you can tell which is doing what.
How much of each should I take?
Ashwagandha's stress trial used 300 mg of root extract twice daily for 60 days. Lion's mane's cognition trial used 3 g a day of dried fruiting body for 16 weeks; the Alzheimer's trial used 1,050 mg of standardised mycelium, which isn't the same material.
Shop Lion's Mane and Ashwagandha
Dried lion's mane (100 g €39, 500 g €169) is the cheapest route to Mori's 3 g daily dose, and lion's mane capsules (120 caps €49) hold 0.5 g each. Ashwagandha capsules (120 caps €29) cover the stress and cognition side at the studied format. Browse Focus & Cognition. Free shipping on orders over €50.
Related Articles
- Ashwagandha vs Reishi for Stress
- Lion's Mane vs Reishi
- Ashwagandha Side Effects and Liver Safety
- Lion's Mane Side Effects and Interactions
- Ashwagandha Dosage Guide
- Lion's Mane Dosage Guide
- Best Mushrooms for Focus and Concentration
Sources
- Zhu X, Zeng Q, Lei Y, Xu D. Effects of Withania somnifera (L.) Dunal (ashwagandha) on cognitive and physical function in adults: a systematic review and meta-analysis. Front Pharmacol. 2026;17:1799467. PubMed 42199854
- Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262. PubMed 23439798
- Docherty S, Doughty FL, Smith EF. The acute and chronic effects of lion's mane mushroom supplementation on cognitive function, stress and mood in young adults: a double-blind, parallel groups, pilot study. Nutrients. 2023;15(22):4842. PubMed 38004235
- Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367-372. PubMed 18844328
- Li IC, Chang HH, Lin CH, et al. Prevention of early Alzheimer's disease by erinacine A-enriched Hericium erinaceus mycelia pilot double-blind placebo-controlled study. Front Aging Neurosci. 2020;12:155. PubMed 32581767
- Salve J, Pate S, Debnath K, Langade D. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. 2019;11(12):e6466. PubMed 32021735